Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation
Background Human γδ T cells expressing Vγ2Vδ2 T cell receptors monitor foreign- and self-prenyl pyrophosphate metabolites in isoprenoid biosynthesis to mediate immunity to microbes and tumors. Adoptive immunotherapy with Vγ2Vδ2 T cells has been used to treat cancer patients with partial and complete...
Saved in:
| Main Authors: | Hong Wang, Mohanad H. Nada, Grefachew Workalemahu, Yoshimasa Tanaka, Craig T. Morita |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2017-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/5/1/9.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An organotypic human melanoma-in-skin model as an in vitro tool for testing Vγ9Vδ2-T cell-based immunotherapy
by: E. Michielon, et al.
Published: (2024-12-01) -
Recognition of MR1-antigen complexes by TCR Vγ9Vδ2
by: José Pedro Loureiro, et al.
Published: (2025-02-01) -
Overcoming antigen loss in CAR T therapy with Vγ9Vδ2 CAR T-cells
by: M. Velasco Santiago, et al.
Published: (2025-06-01) -
From ex vivo to in vitro models: towards a novel approach to investigate the efficacy of immunotherapies on exhausted Vγ9Vδ2 T cells?
by: Morgane Chauvet, et al.
Published: (2025-04-01) -
Autologous Peripheral Vγ9Vδ2 T Cell Synergizes with αβ T Cell Through Antigen Presentation and BTN3A1 Blockade in Immunotherapy of Cervical Cancer
by: Min Wu, et al.
Published: (2025-05-01)